UY34700A - Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné - Google Patents
Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acnéInfo
- Publication number
- UY34700A UY34700A UY0001034700A UY34700A UY34700A UY 34700 A UY34700 A UY 34700A UY 0001034700 A UY0001034700 A UY 0001034700A UY 34700 A UY34700 A UY 34700A UY 34700 A UY34700 A UY 34700A
- Authority
- UY
- Uruguay
- Prior art keywords
- dialil
- pyrfenidone
- semisolid
- odd
- eliminate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención describe una composición tópica semisólida conteniendo Pirfenidona y un antimicrobiano/antiséptico como Dialil Óxido de Disulfuro Modificado (ODD-M) y su proceso de fabricación, que ofrece ventajas sobre otras formas farmacéuticas de administración cutánea conocidas en el estado de la técnica, que es útil como agente anti-fibrótico, anti-inflamatorio y antiséptico en la prevención, tratamiento y reversión del acné y lesiones post-acnéicas. Dicha composición también es útil para disminuir el tono rojizo de la piel, para detener la formación de nuevos brotes de acné, para revertir los brotes ya existentes y para regenerar la piel dañada a consecuencia del acné.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2012003694A MX346763B (es) | 2012-03-28 | 2012-03-28 | Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné. |
Publications (1)
Publication Number | Publication Date |
---|---|
UY34700A true UY34700A (es) | 2013-10-31 |
Family
ID=48096131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001034700A UY34700A (es) | 2012-03-28 | 2013-03-20 | Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné |
Country Status (22)
Country | Link |
---|---|
US (6) | US20150148382A1 (es) |
EP (1) | EP2832354A1 (es) |
JP (1) | JP2015513359A (es) |
KR (1) | KR20140146144A (es) |
CN (1) | CN104334171A (es) |
AR (1) | AR090457A1 (es) |
AU (1) | AU2013240709A1 (es) |
CA (1) | CA2868729C (es) |
CL (1) | CL2014002591A1 (es) |
CO (1) | CO7071140A2 (es) |
CU (1) | CU20140114A7 (es) |
DO (1) | DOP2014000218A (es) |
EA (1) | EA201401031A1 (es) |
IL (1) | IL234816A0 (es) |
IN (1) | IN2014DN08067A (es) |
MA (1) | MA20150062A1 (es) |
MX (1) | MX346763B (es) |
PH (1) | PH12014502154A1 (es) |
SG (1) | SG11201406035VA (es) |
TN (1) | TN2014000396A1 (es) |
UY (1) | UY34700A (es) |
WO (1) | WO2013147577A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2007009796A (es) | 2007-08-14 | 2009-02-25 | Cell Therapy And Technology S | Gel conteniendo pirfenidona. |
MX2011007675A (es) | 2011-07-19 | 2012-07-11 | Cell Therapy And Technology S A De C V | Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas. |
MX346763B (es) | 2012-03-28 | 2017-03-31 | Cell Therapy And Tech S A De C V | Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné. |
MX356551B (es) | 2012-08-23 | 2018-06-04 | Grupo Medifarma S A De C V Star | Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné. |
WO2015153683A1 (en) | 2014-04-02 | 2015-10-08 | Intermune, Inc. | Anti-fibrotic pyridinones |
CN106491517B (zh) * | 2016-11-23 | 2019-12-06 | 佛山科学技术学院 | 吡非尼酮pva水凝胶的制备方法及吡非尼酮pva水凝胶 |
US20180360751A1 (en) * | 2017-06-19 | 2018-12-20 | Advanced Fibrosis Research LLC | Transdermal cream for treating Dupuytren's Contracture |
MX366086B (es) | 2017-08-15 | 2019-06-27 | Cell Therapy And Tech S A De C V | Composicion topica semisolida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños cronicos de la piel. |
MX368750B (es) * | 2018-08-31 | 2019-10-15 | Cell Therapy And Tech S A De C V | Composiciones farmaceuticas semisolidas de base oleosa conteniendo pirfenidona para su aplicacion en la reparacion tisular. |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3839346A (en) | 1972-12-18 | 1974-10-01 | Affiliated Med Res | N-substituted pyridone and general method for preparing pyridones |
CA1049411A (en) | 1972-12-18 | 1979-02-27 | Affiliated Medical Research | N-substituted pyridone and general method for preparing pyridones |
NL7317316A (es) | 1972-12-18 | 1974-06-20 | ||
US4052509A (en) | 1972-12-18 | 1977-10-04 | Affiliated Medical Research, Inc. | Method for reducing serum uric acid levels |
US4042699A (en) | 1972-12-18 | 1977-08-16 | Affiliated Medical Research, Inc. | Method for reducing serum glucose levels |
US4105782A (en) | 1975-03-07 | 1978-08-08 | Yu Ruey J | Treatment of acne and dandruff |
JPS51128433A (en) | 1975-04-30 | 1976-11-09 | Ajinomoto Co Inc | A herbicide |
SE430609B (sv) | 1976-12-21 | 1983-11-28 | Sca Development Ab | Sett att ur cellulosaderivat framstella absorberande material |
US4376118A (en) | 1980-10-06 | 1983-03-08 | Miles Laboratories, Inc. | Stable nonaqueous solution of tetracycline salt |
US5310562A (en) | 1989-11-22 | 1994-05-10 | Margolin Solomon B | Composition and method for reparation and prevention of fibrotic lesions |
US5009895A (en) | 1990-02-02 | 1991-04-23 | Merck & Co., Inc. | Sustained release with high and low viscosity HPMC |
ATE224712T1 (de) | 1993-05-07 | 2002-10-15 | Solomon B Margolin | Zusammensetzungen und verfahren zur reparatur und vorbeugung fibrotischer verletzungen |
PL186795B1 (pl) | 1995-12-21 | 2004-02-27 | Pfizer | Preparat farmaceutyczny zawierający danofloksacynę |
US5958420A (en) | 1997-03-13 | 1999-09-28 | Nortrade Medical, Inc. | Treatment of burns, cuts, and abrasions of the skin |
US6365131B1 (en) | 1997-10-31 | 2002-04-02 | J. B. Chemicals & Pharmaceuticals Ltd. | Pharmaceutical dental formulation for topical application of metronidazole benzoate, chlorhexidine gluconate and local anesthetic |
EP1069898B1 (en) | 1998-03-17 | 2004-05-12 | MARGOLIN, Solomon B. | Topical antiseptic compositions and methods |
GB9810949D0 (en) | 1998-05-22 | 1998-07-22 | Hewlett Healthcare Limited | Formulation |
EP1113798B1 (en) | 1998-09-18 | 2003-01-02 | Mepha AG | Topical formulation of alkyl-, phenyl-pyridone |
US20020028784A1 (en) | 2000-03-10 | 2002-03-07 | Nest Gary Van | Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences |
IN191090B (es) | 2000-08-29 | 2003-09-20 | Ranbanx Lab Ltd | |
KR100777169B1 (ko) | 2001-01-29 | 2007-11-16 | 시오노기세이야쿠가부시키가이샤 | 5-메틸-1-페닐-2-(1h)-피리돈을 활성 성분으로서함유하는 의약 제제 |
US20030103941A1 (en) | 2001-10-09 | 2003-06-05 | Crombleholme Timothy M. | Materials and methods for preventing or reducing scar formation |
CH696420A5 (de) | 2002-09-13 | 2007-06-15 | Mepha Ag | Neue stabile Zubereitungen von Alkyl-, Phenyl-Pyridonen für topische Anwendung. |
TW200501952A (en) | 2003-02-21 | 2005-01-16 | Shionogi & Co | Pirfenidone gel formulations |
WO2004078194A1 (en) | 2003-02-28 | 2004-09-16 | Intermune, Inc. | Interferon drug therapy for the treatment of viral diseases and liver fibrosis |
AU2003299962A1 (en) | 2003-02-28 | 2004-09-28 | Intermune, Inc. | Interferon drug therapy for the treatment of viral diseases and liver fibrosis |
WO2004089283A2 (en) | 2003-04-04 | 2004-10-21 | Intermune, Inc. | Compositions and methods for treating viral infections |
US8222299B2 (en) * | 2003-05-23 | 2012-07-17 | Allium Vitalis Incorporated | Organosulfur prodrugs for the prevention and treatment of infectious diseases |
US20080025986A1 (en) | 2003-06-06 | 2008-01-31 | Ozes Osman N | Methods of Treating Tnf-Mediated Disorders |
US7491794B2 (en) | 2003-10-14 | 2009-02-17 | Intermune, Inc. | Macrocyclic compounds as inhibitors of viral replication |
TWI375679B (en) | 2003-10-14 | 2012-11-01 | Hoffmann La Roche | Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication |
US7407973B2 (en) | 2003-10-24 | 2008-08-05 | Intermune, Inc. | Use of pirfenidone in therapeutic regimens |
US20070258946A1 (en) | 2003-12-23 | 2007-11-08 | Blatt Lawrence M | Combination Therapy for Treating Hepatitis C Virus Infection |
CN100542532C (zh) | 2004-05-24 | 2009-09-23 | 上海睿星基因技术有限公司 | 吡非尼酮在制备治疗肝损伤坏死和急性肺损伤的药物中的用途 |
US20060051339A1 (en) | 2004-09-08 | 2006-03-09 | Sivak Hannah N | Composition for treatment of oily skin and acne prevention and methods of making and using same |
US20060115503A1 (en) | 2004-11-30 | 2006-06-01 | Goyal Muna C | Composition, system and method for treatment of skin |
ES2524922T3 (es) | 2005-05-10 | 2014-12-15 | Intermune, Inc. | Derivados de piridona para modular el sistema de proteína cinasa activada por estrés |
EA015752B1 (ru) | 2005-07-25 | 2011-12-30 | Интермьюн, Инк. | Новые макроциклические ингибиторы репликации вируса гепатита с |
NZ591443A (en) | 2005-09-22 | 2013-04-26 | Intermune Inc | Granule formation of pirfenidone and pharmaceutically acceptable excipients |
BRPI0618939A2 (pt) | 2005-11-23 | 2011-09-13 | Intermune Inc | método para modulação de sistema de proteìna quinase ativada por estresse |
EP1973525B1 (en) | 2005-12-05 | 2014-04-30 | RBA Pharma Inc. | Emulsion-containing medical articles |
CN101088557A (zh) | 2006-06-12 | 2007-12-19 | 天津市扶素生物技术有限公司 | 用于预防或治疗hiv感染的药用组合物及其应用 |
AU2008216382A1 (en) | 2007-02-12 | 2008-08-21 | Array Biopharma, Inc. | Novel inhibitors hepatitis C virus replication |
EP2118107A1 (en) | 2007-03-02 | 2009-11-18 | Talia Miron | Mercaptopurine derivatives as anticancer agents |
US20080287508A1 (en) | 2007-05-18 | 2008-11-20 | Intermune, Inc. | Altering pharmacokinetics of pirfenidone therapy |
JP5587184B2 (ja) | 2007-06-20 | 2014-09-10 | オースペックス・ファーマシューティカルズ・インコーポレイテッド | 繊維症阻害剤としての置換n−アリールピリジノン |
MX2007009796A (es) | 2007-08-14 | 2009-02-25 | Cell Therapy And Technology S | Gel conteniendo pirfenidona. |
US20090137354A1 (en) | 2007-11-27 | 2009-05-28 | Shimano Inc. | Bicycle rear derailleur |
AU2008335717A1 (en) | 2007-12-11 | 2009-06-18 | Coda Therapeutics, Inc. | Impaired wound healing compositions and treatments |
US20100256031A1 (en) | 2008-10-10 | 2010-10-07 | Jeffrey Wu | Shine control cleanser |
US7635707B1 (en) | 2008-11-10 | 2009-12-22 | Intermune, Inc. | Pirfenidone treatment for patients with atypical liver function |
AR075584A1 (es) | 2009-02-27 | 2011-04-20 | Intermune Inc | COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO. |
CN101972236A (zh) | 2010-10-13 | 2011-02-16 | 北京诚创康韵医药科技有限公司 | 一种含吡非尼酮的缓释制剂 |
CN101972225A (zh) | 2010-10-13 | 2011-02-16 | 北京诚创康韵医药科技有限公司 | 一种含吡非尼酮的凝胶组合物 |
EP2670242B1 (en) | 2011-01-31 | 2022-03-16 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
CN103458897A (zh) | 2011-02-15 | 2013-12-18 | 阿勒根公司 | 用于治疗红斑痤疮的症状的羟甲唑啉药物乳膏组合物 |
CN102670632A (zh) | 2011-03-12 | 2012-09-19 | 赵海静 | 吡非尼酮在抑制皮肤瘢痕形成的医药用途 |
CN102670600A (zh) | 2011-03-12 | 2012-09-19 | 赵海静 | 一种抑制瘢痕和促进创口愈合的医药产品,其制备方法和应用 |
US9241921B2 (en) | 2011-05-02 | 2016-01-26 | Pankaj Modi | Photosensitizer composition for treating skin disorders |
MX2011007675A (es) | 2011-07-19 | 2012-07-11 | Cell Therapy And Technology S A De C V | Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas. |
CN102488660A (zh) | 2011-12-15 | 2012-06-13 | 西安天一秦昆制药有限责任公司 | 一种含吡非尼酮的缓释微丸 |
MX346763B (es) | 2012-03-28 | 2017-03-31 | Cell Therapy And Tech S A De C V | Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné. |
WO2013181691A1 (en) | 2012-06-04 | 2013-12-12 | The Macfarlane Burnet Institute For Medical Research And Public Health Ltd | A method of treatment and compositions useful therefor, screening and prognostic agents and uses therefor |
BR112014030623A2 (pt) | 2012-06-12 | 2017-06-27 | Hoffmann La Roche | composição, combinação e respectivos usos |
MX356551B (es) | 2012-08-23 | 2018-06-04 | Grupo Medifarma S A De C V Star | Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné. |
CA2819967C (en) | 2012-08-31 | 2016-03-22 | Intermune, Inc. | Use of pirfenidone concomitantly with ciprofloxacin |
AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
US10953021B2 (en) | 2013-03-15 | 2021-03-23 | Lupin Limited | Topical compositions of flunisolide and methods of treatment |
US9156896B2 (en) | 2013-03-15 | 2015-10-13 | Coda Therapeutics, Inc. | Wound healing compositions and treatments |
MX352342B (es) | 2013-07-12 | 2017-11-22 | Moleculas Naturales S A De C V Star | Un procedimiento para fabricar un complejo mejorado de cloruro de bencetonio-dialil oxido de disulfuro modificado, el complejo obtenido y sus usos. |
CN103550242B (zh) | 2013-11-22 | 2015-07-15 | 四川国康药业有限公司 | 一种治疗肝纤维化的药物组合物及其制备方法 |
GB201508419D0 (en) | 2015-05-15 | 2015-07-01 | Cambridge Entpr Ltd | Detection of T cell exhaustion or lack of T cell costimulation and uses thereof |
US20190000847A1 (en) | 2015-12-16 | 2019-01-03 | Daiichi Sankyo Company Limited | Therapeutic agent for a wound |
JOP20170113B1 (ar) | 2016-05-09 | 2023-03-28 | Bayer Pharma AG | مركبات 5، 6، 7، 8-رباعي هيدرو [1، 2، 4] تريازولو [4، 3-أ] بيريدين 3(2h)-ون مستبدلة ومركبات 2، 5، 6، 7-رباعي هيدرو-3h-بيرولو [2، 1-ج] [1، 2، 4] تريازول-3-ون واستخداماتها |
MX364040B (es) | 2016-11-11 | 2019-04-11 | Cell Therapy And Tech S A De C V | Uso farmacéutico de una composición que contiene pirfenidona de liberación prolongada (pfd-lp) para la reversión y tratamiento de la esteatohepatitis humana (nafld/nash). |
TWI770157B (zh) | 2017-04-10 | 2022-07-11 | 德商拜耳廠股份有限公司 | 經取代之n-芳基乙基-2-胺基喹啉-4-甲醯胺及其用途 |
MX366086B (es) | 2017-08-15 | 2019-06-27 | Cell Therapy And Tech S A De C V | Composicion topica semisolida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños cronicos de la piel. |
MX368750B (es) | 2018-08-31 | 2019-10-15 | Cell Therapy And Tech S A De C V | Composiciones farmaceuticas semisolidas de base oleosa conteniendo pirfenidona para su aplicacion en la reparacion tisular. |
-
2012
- 2012-03-28 MX MX2012003694A patent/MX346763B/es active IP Right Grant
-
2013
- 2013-02-27 AU AU2013240709A patent/AU2013240709A1/en not_active Abandoned
- 2013-02-27 CN CN201380023489.8A patent/CN104334171A/zh active Pending
- 2013-02-27 EP EP13716457.0A patent/EP2832354A1/en not_active Withdrawn
- 2013-02-27 US US14/388,447 patent/US20150148382A1/en not_active Abandoned
- 2013-02-27 WO PCT/MX2013/000027 patent/WO2013147577A1/es active Application Filing
- 2013-02-27 CA CA2868729A patent/CA2868729C/en active Active
- 2013-02-27 KR KR1020147030122A patent/KR20140146144A/ko not_active Application Discontinuation
- 2013-02-27 JP JP2015503144A patent/JP2015513359A/ja active Pending
- 2013-02-27 IN IN8067DEN2014 patent/IN2014DN08067A/en unknown
- 2013-02-27 EA EA201401031A patent/EA201401031A1/ru unknown
- 2013-02-27 MA MA37377A patent/MA20150062A1/fr unknown
- 2013-02-27 SG SG11201406035VA patent/SG11201406035VA/en unknown
- 2013-03-20 UY UY0001034700A patent/UY34700A/es unknown
- 2013-03-21 AR ARP130100926A patent/AR090457A1/es unknown
-
2014
- 2014-09-22 TN TNP2014000396A patent/TN2014000396A1/fr unknown
- 2014-09-23 IL IL234816A patent/IL234816A0/en unknown
- 2014-09-24 CO CO14211037A patent/CO7071140A2/es unknown
- 2014-09-26 CU CU2014000114A patent/CU20140114A7/es unknown
- 2014-09-26 PH PH12014502154A patent/PH12014502154A1/en unknown
- 2014-09-26 CL CL2014002591A patent/CL2014002591A1/es unknown
- 2014-09-26 DO DO2014000218A patent/DOP2014000218A/es unknown
-
2016
- 2016-04-14 US US15/098,970 patent/US9949959B2/en active Active
-
2018
- 2018-03-14 US US15/920,822 patent/US20180214434A1/en not_active Abandoned
-
2019
- 2019-08-07 US US16/534,980 patent/US11013727B2/en active Active
-
2021
- 2021-05-24 US US17/328,685 patent/US11766426B2/en active Active
-
2023
- 2023-08-15 US US18/449,747 patent/US20240216350A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
PH12014502154A1 (en) | 2014-12-10 |
IN2014DN08067A (es) | 2015-05-01 |
EA201401031A1 (ru) | 2015-05-29 |
MX2012003694A (es) | 2013-09-30 |
MA20150062A1 (fr) | 2015-02-27 |
US11766426B2 (en) | 2023-09-26 |
CA2868729C (en) | 2020-10-20 |
EP2832354A1 (en) | 2015-02-04 |
US20200061040A1 (en) | 2020-02-27 |
US20180214434A1 (en) | 2018-08-02 |
US20150148382A1 (en) | 2015-05-28 |
MX346763B (es) | 2017-03-31 |
DOP2014000218A (es) | 2014-12-15 |
CL2014002591A1 (es) | 2015-01-16 |
AR090457A1 (es) | 2014-11-12 |
CO7071140A2 (es) | 2014-09-30 |
US11013727B2 (en) | 2021-05-25 |
US20160228424A1 (en) | 2016-08-11 |
IL234816A0 (en) | 2014-12-31 |
US9949959B2 (en) | 2018-04-24 |
CN104334171A (zh) | 2015-02-04 |
TN2014000396A1 (en) | 2015-12-21 |
JP2015513359A (ja) | 2015-05-11 |
KR20140146144A (ko) | 2014-12-24 |
CA2868729A1 (en) | 2013-10-03 |
SG11201406035VA (en) | 2014-11-27 |
AU2013240709A1 (en) | 2014-11-06 |
CU20140114A7 (es) | 2015-01-29 |
WO2013147577A1 (es) | 2013-10-03 |
US20240216350A1 (en) | 2024-07-04 |
US20210346360A1 (en) | 2021-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY34700A (es) | Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné | |
UY34763A (es) | Inhibidores de la agregación plaquetaria | |
UY34820A (es) | Compuestos tipo pirrolo-pirrolidinona | |
UY34750A (es) | ?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?. | |
UY4211Q (es) | Pizarra para marcadores | |
UY34571A (es) | Composiciones herbicidas que contienen bentazón y el inhibidor als y el inhibidor accasa. | |
UY34648A (es) | Amidas como inhibidores de pim | |
UY34817A (es) | Tienopirimidinas | |
UY34550A (es) | Bencilpirazoles sustituidos | |
UY34683A (es) | Esteviol glucosiltransferasas y genes que las codifican | |
UY4230Q (es) | Bocadillo retorcido para mascota | |
UY4234Q (es) | Configuración aplicada en zapato | |
BR112015012907A2 (pt) | composição de cuidado pessoal | |
UY34740A (es) | Atomizador con agentes codificadores | |
RS53893B1 (en) | USE OF BIOTIN FOR MULTIPLE SCLEROSIS TREATMENT | |
UY34167A (es) | Pirrolotriazinas sustituidas con hidroximetilarilo y sus usos | |
UY34541A (es) | ?derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina?. | |
UY34616A (es) | Nuevo compuesto útil para el tratamiento de enfermedades degenerativas e inflamatorias. | |
PE20151435A1 (es) | Laquinimod para reducir el dano talamico en la esclerosis multiple | |
UY34800A (es) | Combinaciones farmacéuticas que contienen un inhibidor de 11-beta-hidroxiesteroide dehidrogenasa-1 útil en trastornos metabólicos | |
MX366765B (es) | Agonistas de receptores gamma activados por el proliferador de peroxisoma para el tratamiento de esclerósis múltiple. | |
PH12017501071A1 (en) | Dihydropyrimidin-2-one compounds and medical use thereof | |
UY34590A (es) | Fenilimidazopirazoles sustituidos y su uso | |
IN2014DN11078A (es) | ||
UY4241Q (es) | Mesa |